Exclusive

Shionogi and F2G report Phase 3 results for oral antifungal olorofim

Singapore, Oct. 22 -- Shionogi and F2G have reported detailed results from the global Phase 3 OASIS study evaluating investigational oral antifungal olorofim against AmBisome, followed by standard of ... Read More


DOBBS Community and OncoCare strengthen early cancer detection pathways in Malaysia

Singapore, Oct. 22 -- DOBBS Community and OncoCare have joined forces to strengthen cancer awareness, early detection and access to appropriate specialist care in Malaysia through the GP Onco Navigato... Read More


EQT to Acquire QIAGEN in Landmark €10.8 Billion Take-Private Deal

Singapore, Oct. 22 -- QIAGEN N.V. and EQT XI fund ("EQT Private Equity") announced an agreement under which Crown NL Bidco B.V. (the "Bidder") announced its decision to make an all-cash voluntary publ... Read More


Healthcare's AI Ambitions Are Colliding With a Data Wall

Singapore, Oct. 21 -- Healthcare is generating more data than ever, yet much of its potential remains locked within disconnected systems. As artificial intelligence reshapes clinical decision-making a... Read More


Nxera Pharma Japan licenses Quviviq to Taiwan's Synmosa Biopharma in 8 APAC markets

Singapore, Oct. 19 -- Nxera Pharma has announced that its subsidiary, Nxera Pharma Japan has entered into an exclusive license, supply and commercialisation agreement with Taiwan-headquartered Synmosa... Read More


S2N.Bio begins Alzheimer's cell therapy technology transfer to Cell Therapies' Melbourne GMP facility

Singapore, Oct. 19 -- Cell Therapies Pty Ltd (CTPL) and S2N.Bio have commenced technology transfer of S2N's cell therapy candidate for Alzheimer's disease. The transfer will enable GMP manufacture of ... Read More


HistoIndex partners with A*STAR to advance early-stage development of pipeline therapies for fibrotic diseases in Singapore

Singapore, Oct. 19 -- HistoIndex, a pioneer in AI-driven digital pathology for fibrotic diseases, and the Agency for Science, Technology and Research (A*STAR), Singapore's lead public sector R&D agenc... Read More


Merck inaugurates State-of-the-Art ADVANCE Bioanalytical Facility in US

Singapore, Oct. 19 -- Merck, known as MSD outside of the United States and Canada, has inaugurated its state-of-the-art ADVANCE research facility on its West Point, Pennsylvania, campus, signaling a n... Read More


Researchers in Korea explore use of smartphones to help detect lung problems in children

Singapore, Oct. 19 -- Respiratory disease in children is a major global concern. Although stethoscopes help clinicians detect abnormal lung sounds, access to auscultation may be limited by the need fo... Read More


Taiwan's Jyong Biotech to establish new manufacturing facility and US operations centre in Texas

Singapore, Oct. 17 -- Jyong Biotech, a Taiwan-based science-driven biotechnology company dedicated to the development and commercialisation of innovative plant-derived therapeutics, has announced that... Read More